| abstract |
There is disclosed compositions and methods relating to or derived from anti-WISPl antibodies. More specifically, there is disclosed fully human antibodies that bind WISP1, WISP1 -binding fragments and derivatives of such antibodies, and WISP1 -binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having WISP1 related disorders or conditions. There is also disclosed a method for treating or preventing various cancers or inflammatory diseases and various diseases of the heart, bone/joints or lung. |